Company: RVRC
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-013823
Chunk: 23

Company: Revium Rx.
Filing Date: 2025-02-14
Form: S-1
Chunk 23
---
 our systems or the unauthorized or inadvertent wrongful use or disclosure of confidential information that could adversely affect our business operations or result in the loss, dissemination or misuse of critical or sensitive information. The increasing sophistication and frequency of cybersecurity threats, including targeted data breaches, ransomware attacks designed to encrypt our data for ransom and other malicious cyber activities, pose a significant risk to the integrity and confidentiality of our data systems. A breach our security measures or the accidental loss, inadvertent disclosure, unapproved dissemination, misappropriation or misuse of trade secrets, proprietary information or other confidential information, whether as a result of theft, hacking, fraud, trickery or other forms of deception, or for any other cause, could enable others to produce competing products, use our proprietary technology or information, and/or adversely affect our business position. Further, any such interruption, security breach, loss or disclosure of confidential information could result in financial, legal, business and reputational harm to us and could have a material adverse effect on our business, financial position, results of operations and/or cash flow.

<div align='center'>13</div>

Our Technology May Become Obsolete or Lose its Competitive Advantage.

The new drug development business is very competitive, fast moving and intense, and expected to be increasingly so in the future. Other companies and research institutions are developing novel medicines that, if not similar in type to our systems, are designed to address the same patient or subject population. We cannot ensure you that our products will be the best, the safest, the first to market, or the most economical to manufacture and use. If competitors’ products are better than ours, for whatever reason, then we could become less profitable from product sales and our products could become obsolete.

There are many reasons why a competitor might be more successful than us, including:

| ● | Financial                                                                                  
 Resources. Some competitors have greater financial resources and can afford more technical 
 and developmental setbacks than we can.                                                    |

| ● | Greater                                                                                            
 Experience. Some competitors have been in the biotechnology business longer than we have.          
 They have greater experience than us in critical areas like clinical testing, obtaining regulatory 
 approval and sales and marketing. This experience or their name recognition may give them          
 a competitive advantage over us. In certain international markets, local companies may be          
 given preferential treatment by local physicians and hospitals.                                    |

| ● | Superior                                                                                   
 Patent Position. Some competitors may have better patent protection over their technology  
 than we have or will have in order to protect our technology. If we cannot